ASX - By Stock
|
TIE |
Re:
Ann: Notice that defeating conditions to takeover bid freed
|
|
stockrock
|
2 |
753 |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
2
|
753
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
115K |
112 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
273
|
115K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
115K |
73 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
273
|
115K
|
73
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
80 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
551
|
200K
|
80
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
48 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
551
|
200K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
stockrock
|
590 |
222K |
8 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
590
|
222K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
stockrock
|
590 |
222K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
590
|
222K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
115K |
51 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
115K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
44 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
551
|
200K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
115K |
39 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
115K
|
39
|
|
ASX - By Stock
|
MSB |
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
115K |
214 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
273
|
115K
|
214
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
21 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
551
|
200K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
200K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
12 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
200K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
551 |
200K |
46 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
200K
|
46
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
172K |
24 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
549
|
172K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
172K |
39 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
172K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
172K |
24 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
172K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
172K |
18 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
172K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
172K |
49 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
172K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
stockrock
|
272 |
99K |
67 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
272
|
99K
|
67
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Gas Sales MOU Signed for 500MW Gas to Power Project
|
|
stockrock
|
306 |
101K |
20 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
306
|
101K
|
20
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2023 and beyond
|
|
stockrock
|
2.9K |
1.4M |
71 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
2.9K
|
1.4M
|
71
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.8K |
1.9M |
10 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
4.8K
|
1.9M
|
10
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
411 |
174K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
411
|
174K
|
4
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
411 |
174K |
15 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
411
|
174K
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.8K |
1.9M |
12 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.8K
|
1.9M
|
12
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.8K |
1.9M |
13 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.8K
|
1.9M
|
13
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.8K |
1.9M |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.8K
|
1.9M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.8K |
1.9M |
24 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.8K
|
1.9M
|
24
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
411 |
174K |
32 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
411
|
174K
|
32
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
stockrock
|
20K |
6.7M |
9 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
20K
|
6.7M
|
9
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
75K |
6 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
75K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
75K |
3 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
75K
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
75K |
6 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
75K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
75K |
13 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
75K
|
13
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
75K |
14 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
75K
|
14
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
765 |
262K |
17 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
765
|
262K
|
17
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
765 |
262K |
13 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
765
|
262K
|
13
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Investor Presentation
|
|
stockrock
|
127 |
44K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
127
|
44K
|
2
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Hydrocarbon gas recovered & evaluation program forward plan
|
|
stockrock
|
1.6K |
451K |
11 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1.6K
|
451K
|
11
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
stockrock
|
32K |
15M |
5 |
20/11/23 |
20/11/23 |
Charts
|
32K
|
15M
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
stockrock
|
32K |
15M |
2 |
20/11/23 |
20/11/23 |
Charts
|
32K
|
15M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
stockrock
|
32K |
15M |
3 |
20/11/23 |
20/11/23 |
Charts
|
32K
|
15M
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Hydrocarbon gas recovered & evaluation program forward plan
|
|
stockrock
|
1.6K |
451K |
3 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
1.6K
|
451K
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Hydrocarbon gas recovered & evaluation program forward plan
|
|
stockrock
|
1.6K |
451K |
7 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
1.6K
|
451K
|
7
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Hydrocarbon gas recovered & evaluation program forward plan
|
|
stockrock
|
1.6K |
451K |
6 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
1.6K
|
451K
|
6
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit's ReRAM IP achieves high temperature qualification
|
|
stockrock
|
42 |
18K |
14 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
42
|
18K
|
14
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit's ReRAM IP achieves high temperature qualification
|
|
stockrock
|
42 |
18K |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
42
|
18K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit's ReRAM IP achieves high temperature qualification
|
|
stockrock
|
42 |
18K |
9 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
42
|
18K
|
9
|
|